Clinical Trial Update: Effects of Delta-9 Tetrahydrocannabinol (THC) on Retention of Memory for Fear Extinction Learning in PTSD: R61 Study [Phase 4]

View source ↗

Summary

Phase 4 trial update examining the effects of Delta-9-tetrahydrocannabinol (THC) on retention of fear extinction learning in post-traumatic stress disorder; the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-traumatic Stress Disorder

Drugs mentioned

• Delta-9-tetrahydrocannabinol (tetrahydrocannabinol (THC))

Snippet

Sponsor: Wayne State University | Conditions: PostTraumatic Stress Disorder | Phase 4 | Status: COMPLETED | Results posted: 2022-09-08